Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR

Rashmee U Shah1, James A de Lemos2, Tracy Y Wang3

  • 1University of Utah, Division of Cardiovascular Medicine, Salt Lake City, Utah.

Insights

Patients surviving acute myocardial infarction (AMI) with cardiogenic shock face higher early post-discharge death and hospitalization risks. Prognosis becomes similar to non-shock patients after 60 days.

Area of Science:

  • Cardiology
  • Clinical Outcomes Research

Background:

  • Many patients with acute myocardial infarction (AMI) and cardiogenic shock survive hospitalization.
  • Prognosis for these patients after discharge is not well understood.

Purpose of the Study:

  • To evaluate the association between cardiogenic shock and post-discharge mortality.
  • To assess the link between cardiogenic shock and all-cause hospitalization in AMI survivors.

Main Methods:

  • Analysis of 112,668 AMI survivors (≥65 years) from the ACTION Registry-GWTG linked with Medicare claims.
  • Use of proportional hazards models to assess outcomes at 60 days and 1 year post-discharge.
  • Adjustment for patient and hospital characteristics.

Main Results:

  • 5% of AMI survivors experienced cardiogenic shock.
  • Cardiogenic shock patients had higher mortality at 60 days (9.6% vs. 5.5%) and 1 year (22.4% vs. 16.7%).
  • Adjusted HR for death was higher in the first 60 days (1.62) but similar thereafter (1.08).
  • All-cause hospitalization or death was higher at 60 days (33.9% vs. 24.9%) and 1 year (59.1% vs. 52.3%).
  • Adjusted HR for hospitalization or death was higher in the first 60 days (1.28) and similar thereafter (0.95).

Conclusions:

  • Hospital survivors of AMI with cardiogenic shock face elevated risks of death and hospitalization within the first year post-discharge.
  • This increased risk is concentrated in the early post-discharge period (first 60 days).
  • After 60 days, the prognosis for AMI survivors with and without cardiogenic shock becomes similar.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...